Immunome, Inc. revenue breakdown overview

Immunome, Inc. revenue for the last year amounted to 9.04 M USD, the most of which — 9.04 M USD — came from its highest performing source at the moment, Targeted Oncology Therapies, the year earlier bringing 14.02 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Immunome, Inc. 9.04 M USD, and the year before that — 14.02 M USD.